| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Piperazines | 3 | 2015 | 272 | 0.880 |
Why?
|
| Aortic Aneurysm, Thoracic | 2 | 2021 | 87 | 0.810 |
Why?
|
| Lacerations | 1 | 2021 | 28 | 0.780 |
Why?
|
| Blood Vessel Prosthesis Implantation | 2 | 2021 | 208 | 0.750 |
Why?
|
| Endovascular Procedures | 2 | 2021 | 218 | 0.710 |
Why?
|
| Cyclin-Dependent Kinase 6 | 1 | 2015 | 13 | 0.550 |
Why?
|
| Cyclin-Dependent Kinase 4 | 1 | 2015 | 28 | 0.550 |
Why?
|
| Antineoplastic Agents | 3 | 2017 | 2360 | 0.510 |
Why?
|
| Pyridines | 1 | 2015 | 310 | 0.470 |
Why?
|
| Coronary Thrombosis | 1 | 2013 | 14 | 0.460 |
Why?
|
| Foramen Ovale, Patent | 1 | 2013 | 18 | 0.450 |
Why?
|
| Philadelphia Chromosome | 1 | 2012 | 38 | 0.440 |
Why?
|
| Intensive Care Units, Neonatal | 2 | 2021 | 64 | 0.430 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2012 | 179 | 0.410 |
Why?
|
| Silicones | 1 | 2011 | 16 | 0.400 |
Why?
|
| Peritonitis | 1 | 2011 | 29 | 0.400 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2015 | 589 | 0.400 |
Why?
|
| Drainage | 2 | 2011 | 157 | 0.390 |
Why?
|
| Peritoneal Dialysis | 1 | 2011 | 32 | 0.390 |
Why?
|
| Leukemia | 1 | 2012 | 320 | 0.370 |
Why?
|
| Pulmonary Embolism | 1 | 2013 | 222 | 0.370 |
Why?
|
| Pyrimidines | 2 | 2012 | 370 | 0.370 |
Why?
|
| Evolution, Chemical | 2 | 2005 | 4 | 0.320 |
Why?
|
| Anti-Bacterial Agents | 4 | 2022 | 747 | 0.310 |
Why?
|
| Alanine | 2 | 2005 | 85 | 0.270 |
Why?
|
| Infant, Low Birth Weight | 2 | 2018 | 58 | 0.260 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 4 | 2015 | 375 | 0.240 |
Why?
|
| Cardiac Valve Annuloplasty | 1 | 2023 | 13 | 0.240 |
Why?
|
| Atrioventricular Block | 1 | 2023 | 23 | 0.230 |
Why?
|
| Leukomalacia, Periventricular | 1 | 2023 | 18 | 0.230 |
Why?
|
| Infant, Newborn | 7 | 2023 | 2379 | 0.230 |
Why?
|
| Blood Platelet Disorders | 1 | 2023 | 9 | 0.230 |
Why?
|
| Amikacin | 2 | 2022 | 5 | 0.230 |
Why?
|
| Purpura, Thrombocytopenic, Idiopathic | 1 | 2023 | 12 | 0.220 |
Why?
|
| Lymphohistiocytosis, Hemophagocytic | 1 | 2023 | 18 | 0.220 |
Why?
|
| Cell Line, Tumor | 5 | 2017 | 2426 | 0.220 |
Why?
|
| Thyroxine | 2 | 2017 | 344 | 0.210 |
Why?
|
| Infant, Newborn, Diseases | 1 | 2023 | 111 | 0.210 |
Why?
|
| Hypothyroidism | 2 | 2017 | 232 | 0.210 |
Why?
|
| Prosthesis Design | 2 | 2021 | 278 | 0.210 |
Why?
|
| Tricuspid Valve Insufficiency | 1 | 2023 | 111 | 0.210 |
Why?
|
| Renal Insufficiency | 1 | 2022 | 114 | 0.210 |
Why?
|
| Brain Diseases | 1 | 2023 | 180 | 0.210 |
Why?
|
| Heart Valve Prosthesis Implantation | 1 | 2023 | 166 | 0.200 |
Why?
|
| Dental Pulp | 1 | 2021 | 4 | 0.200 |
Why?
|
| Fibroblast Growth Factor 7 | 1 | 2021 | 10 | 0.200 |
Why?
|
| Humans | 32 | 2023 | 86678 | 0.200 |
Why?
|
| Vancomycin | 1 | 2021 | 72 | 0.200 |
Why?
|
| Aortography | 1 | 2021 | 63 | 0.200 |
Why?
|
| Endoleak | 1 | 2021 | 35 | 0.200 |
Why?
|
| Blood Vessel Prosthesis | 2 | 2021 | 228 | 0.190 |
Why?
|
| Cell Proliferation | 3 | 2021 | 1579 | 0.190 |
Why?
|
| Stents | 2 | 2021 | 377 | 0.180 |
Why?
|
| Otorhinolaryngologic Diseases | 1 | 2018 | 8 | 0.170 |
Why?
|
| Epilepsy | 1 | 2023 | 397 | 0.170 |
Why?
|
| Precursor B-Cell Lymphoblastic Leukemia-Lymphoma | 2 | 2010 | 44 | 0.160 |
Why?
|
| Proteus Syndrome | 1 | 2018 | 1 | 0.160 |
Why?
|
| Umbilical Cord | 1 | 2018 | 40 | 0.160 |
Why?
|
| Heart Transplantation | 1 | 2023 | 705 | 0.160 |
Why?
|
| Bacteremia | 1 | 2018 | 99 | 0.160 |
Why?
|
| Bortezomib | 1 | 2017 | 76 | 0.160 |
Why?
|
| Goiter | 1 | 2017 | 43 | 0.150 |
Why?
|
| Treatment Outcome | 6 | 2023 | 7998 | 0.150 |
Why?
|
| Hypoglycemia | 1 | 2018 | 107 | 0.150 |
Why?
|
| Fetal Diseases | 1 | 2017 | 81 | 0.150 |
Why?
|
| Fusion Proteins, bcr-abl | 2 | 2015 | 107 | 0.150 |
Why?
|
| Oligopeptides | 1 | 2017 | 179 | 0.140 |
Why?
|
| Male | 13 | 2021 | 40988 | 0.140 |
Why?
|
| Cyclin D2 | 1 | 2015 | 19 | 0.140 |
Why?
|
| Cell Cycle Checkpoints | 1 | 2015 | 63 | 0.130 |
Why?
|
| Hot Temperature | 3 | 2005 | 206 | 0.130 |
Why?
|
| Apoptosis | 3 | 2015 | 1683 | 0.130 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2015 | 104 | 0.130 |
Why?
|
| Infant | 5 | 2023 | 3047 | 0.130 |
Why?
|
| Mutation | 3 | 2018 | 3968 | 0.120 |
Why?
|
| Imatinib Mesylate | 2 | 2012 | 126 | 0.120 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2015 | 458 | 0.120 |
Why?
|
| Tissue Donors | 2 | 2023 | 464 | 0.120 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2015 | 1961 | 0.120 |
Why?
|
| Benzamides | 2 | 2012 | 229 | 0.110 |
Why?
|
| Hemangioma | 1 | 2013 | 60 | 0.110 |
Why?
|
| Aircraft | 1 | 2013 | 20 | 0.110 |
Why?
|
| Heart Neoplasms | 1 | 2013 | 62 | 0.110 |
Why?
|
| B-Lymphocytes | 1 | 2017 | 724 | 0.110 |
Why?
|
| Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2012 | 112 | 0.110 |
Why?
|
| Granulocyte Colony-Stimulating Factor | 1 | 2012 | 165 | 0.110 |
Why?
|
| Marfan Syndrome | 1 | 2011 | 28 | 0.100 |
Why?
|
| Ductus Arteriosus, Patent | 1 | 2011 | 38 | 0.100 |
Why?
|
| Japan | 3 | 2023 | 307 | 0.100 |
Why?
|
| Phenotype | 1 | 2018 | 2380 | 0.100 |
Why?
|
| Interleukin-6 | 1 | 2012 | 256 | 0.100 |
Why?
|
| Aortic Aneurysm | 1 | 2011 | 80 | 0.100 |
Why?
|
| Propionibacterium | 1 | 2010 | 6 | 0.100 |
Why?
|
| Naphthols | 1 | 2010 | 4 | 0.100 |
Why?
|
| Cancer Care Facilities | 1 | 2011 | 28 | 0.100 |
Why?
|
| Critical Pathways | 1 | 2011 | 35 | 0.100 |
Why?
|
| Vascular Surgical Procedures | 1 | 2011 | 148 | 0.090 |
Why?
|
| Benchmarking | 1 | 2011 | 79 | 0.090 |
Why?
|
| Serositis | 1 | 2010 | 3 | 0.090 |
Why?
|
| Equipment Design | 1 | 2011 | 407 | 0.090 |
Why?
|
| Adrenal Insufficiency | 1 | 2010 | 23 | 0.090 |
Why?
|
| Dietary Supplements | 1 | 2010 | 128 | 0.090 |
Why?
|
| Accidental Falls | 1 | 2010 | 50 | 0.090 |
Why?
|
| Rectal Neoplasms | 1 | 2011 | 116 | 0.090 |
Why?
|
| Siblings | 1 | 2010 | 111 | 0.090 |
Why?
|
| Drug Monitoring | 2 | 2021 | 118 | 0.090 |
Why?
|
| Translocation, Genetic | 1 | 2010 | 265 | 0.090 |
Why?
|
| Hypotension | 1 | 2010 | 70 | 0.090 |
Why?
|
| Wounds, Nonpenetrating | 1 | 2010 | 92 | 0.090 |
Why?
|
| Bone Marrow Transplantation | 1 | 2010 | 286 | 0.080 |
Why?
|
| Disease Models, Animal | 1 | 2015 | 2231 | 0.080 |
Why?
|
| Aged | 4 | 2021 | 18423 | 0.080 |
Why?
|
| Diagnosis, Differential | 1 | 2013 | 1566 | 0.080 |
Why?
|
| Heart Ventricles | 1 | 2013 | 760 | 0.080 |
Why?
|
| Echocardiography | 1 | 2013 | 911 | 0.080 |
Why?
|
| Cold Temperature | 2 | 2005 | 157 | 0.080 |
Why?
|
| Stomach Neoplasms | 1 | 2011 | 266 | 0.080 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2010 | 381 | 0.080 |
Why?
|
| Germanium | 1 | 2007 | 4 | 0.080 |
Why?
|
| Myeloid-Lymphoid Leukemia Protein | 1 | 2007 | 72 | 0.080 |
Why?
|
| Graft vs Host Disease | 1 | 2010 | 365 | 0.080 |
Why?
|
| Silicon | 1 | 2007 | 18 | 0.080 |
Why?
|
| Isoantigens | 1 | 2007 | 66 | 0.080 |
Why?
|
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2007 | 74 | 0.070 |
Why?
|
| Lasers | 1 | 2007 | 106 | 0.070 |
Why?
|
| Myelodysplastic Syndromes | 1 | 2010 | 346 | 0.070 |
Why?
|
| Nanostructures | 1 | 2007 | 77 | 0.070 |
Why?
|
| Colonic Neoplasms | 1 | 2011 | 558 | 0.070 |
Why?
|
| Stem Cell Transplantation | 1 | 2007 | 183 | 0.070 |
Why?
|
| Neutrophils | 1 | 2007 | 307 | 0.070 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2013 | 2601 | 0.070 |
Why?
|
| Phosphorylation | 2 | 2007 | 1106 | 0.070 |
Why?
|
| Erythrocyte Membrane | 1 | 2005 | 60 | 0.070 |
Why?
|
| Environment | 2 | 2004 | 219 | 0.070 |
Why?
|
| Stereoisomerism | 1 | 2005 | 102 | 0.060 |
Why?
|
| Phospholipids | 1 | 2005 | 111 | 0.060 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 2 | 2007 | 379 | 0.060 |
Why?
|
| Cytarabine | 1 | 2005 | 218 | 0.060 |
Why?
|
| Kidney | 2 | 2022 | 1242 | 0.060 |
Why?
|
| Adenine Nucleotides | 1 | 2004 | 63 | 0.060 |
Why?
|
| Alprostadil | 1 | 2004 | 25 | 0.060 |
Why?
|
| Hepatic Veno-Occlusive Disease | 1 | 2004 | 19 | 0.060 |
Why?
|
| Female | 11 | 2023 | 44550 | 0.060 |
Why?
|
| Phosphates | 1 | 2004 | 160 | 0.060 |
Why?
|
| Antimetabolites, Antineoplastic | 1 | 2005 | 236 | 0.060 |
Why?
|
| Child | 5 | 2023 | 6928 | 0.060 |
Why?
|
| Thyroiditis, Autoimmune | 1 | 2003 | 16 | 0.060 |
Why?
|
| Heparin | 1 | 2004 | 175 | 0.060 |
Why?
|
| Anemia, Aplastic | 1 | 2003 | 30 | 0.060 |
Why?
|
| Pregnancy | 2 | 2023 | 2894 | 0.060 |
Why?
|
| Infant, Very Low Birth Weight | 1 | 2023 | 52 | 0.060 |
Why?
|
| Tricuspid Valve | 1 | 2023 | 96 | 0.060 |
Why?
|
| Birth Weight | 1 | 2023 | 145 | 0.050 |
Why?
|
| Proto-Oncogene Proteins c-akt | 2 | 2018 | 322 | 0.050 |
Why?
|
| Mice | 1 | 2015 | 11356 | 0.050 |
Why?
|
| Carcinoma, Papillary | 1 | 2003 | 158 | 0.050 |
Why?
|
| Middle Aged | 4 | 2013 | 25040 | 0.050 |
Why?
|
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 1 | 2002 | 173 | 0.050 |
Why?
|
| Chromosome Aberrations | 1 | 2023 | 387 | 0.050 |
Why?
|
| Aquaporin 5 | 1 | 2021 | 3 | 0.050 |
Why?
|
| Arabidopsis Proteins | 1 | 2002 | 137 | 0.050 |
Why?
|
| Vimentin | 1 | 2021 | 44 | 0.050 |
Why?
|
| Neoplastic Stem Cells | 1 | 2002 | 143 | 0.050 |
Why?
|
| Retrospective Studies | 3 | 2023 | 8496 | 0.050 |
Why?
|
| Membrane Proteins | 1 | 2007 | 1196 | 0.050 |
Why?
|
| Animals | 2 | 2021 | 26590 | 0.050 |
Why?
|
| Membrane Glycoproteins | 1 | 2002 | 428 | 0.050 |
Why?
|
| Cerebral Hemorrhage | 1 | 2023 | 325 | 0.040 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2002 | 683 | 0.040 |
Why?
|
| Stem Cells | 1 | 2021 | 351 | 0.040 |
Why?
|
| Thyroid Neoplasms | 1 | 2003 | 408 | 0.040 |
Why?
|
| Incidence | 1 | 2023 | 1578 | 0.040 |
Why?
|
| Brain Stem | 1 | 2018 | 165 | 0.040 |
Why?
|
| Respiratory Tract Infections | 1 | 2018 | 105 | 0.040 |
Why?
|
| Antithyroid Agents | 1 | 2017 | 20 | 0.040 |
Why?
|
| Propylthiouracil | 1 | 2017 | 24 | 0.040 |
Why?
|
| Graves Disease | 1 | 2017 | 36 | 0.040 |
Why?
|
| Prenatal Diagnosis | 1 | 2018 | 104 | 0.040 |
Why?
|
| Gestational Age | 1 | 2018 | 311 | 0.040 |
Why?
|
| Creatinine | 1 | 2018 | 339 | 0.040 |
Why?
|
| Biomarkers | 2 | 2018 | 1718 | 0.040 |
Why?
|
| Body Weight | 1 | 2018 | 459 | 0.040 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2004 | 878 | 0.040 |
Why?
|
| Pandemics | 1 | 2023 | 740 | 0.040 |
Why?
|
| DNA Mutational Analysis | 1 | 2018 | 526 | 0.040 |
Why?
|
| Ultrasonography, Prenatal | 1 | 2017 | 152 | 0.040 |
Why?
|
| RNA, Messenger | 1 | 2021 | 1981 | 0.030 |
Why?
|
| Adolescent | 4 | 2011 | 8984 | 0.030 |
Why?
|
| Cell Differentiation | 1 | 2021 | 1458 | 0.030 |
Why?
|
| Rats | 1 | 2021 | 3992 | 0.030 |
Why?
|
| Pregnancy Complications | 1 | 2017 | 336 | 0.030 |
Why?
|
| Time Factors | 2 | 2011 | 5214 | 0.030 |
Why?
|
| Risk Factors | 1 | 2023 | 5420 | 0.030 |
Why?
|
| Neoplasm Invasiveness | 1 | 2013 | 552 | 0.030 |
Why?
|
| Severity of Illness Index | 2 | 2010 | 1802 | 0.020 |
Why?
|
| Fermentation | 1 | 2010 | 13 | 0.020 |
Why?
|
| Bifidobacterium | 1 | 2010 | 16 | 0.020 |
Why?
|
| Laparotomy | 1 | 2011 | 59 | 0.020 |
Why?
|
| Culture Media | 1 | 2010 | 147 | 0.020 |
Why?
|
| Adult | 3 | 2017 | 25659 | 0.020 |
Why?
|
| Urea | 1 | 2010 | 58 | 0.020 |
Why?
|
| Hyponatremia | 1 | 2010 | 25 | 0.020 |
Why?
|
| Histocompatibility | 1 | 2010 | 71 | 0.020 |
Why?
|
| Cross-Over Studies | 1 | 2010 | 399 | 0.020 |
Why?
|
| Peptides | 2 | 2003 | 639 | 0.020 |
Why?
|
| Mycophenolic Acid | 1 | 2010 | 87 | 0.020 |
Why?
|
| Oncogene Proteins, Fusion | 1 | 2010 | 128 | 0.020 |
Why?
|
| Quality Indicators, Health Care | 1 | 2011 | 145 | 0.020 |
Why?
|
| Hospital Mortality | 1 | 2011 | 350 | 0.020 |
Why?
|
| Young Adult | 2 | 2011 | 5980 | 0.020 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2011 | 861 | 0.020 |
Why?
|
| Tablets | 1 | 2010 | 118 | 0.020 |
Why?
|
| Quinolines | 1 | 2010 | 95 | 0.020 |
Why?
|
| Magnetic Resonance Angiography | 1 | 2011 | 262 | 0.020 |
Why?
|
| Reoperation | 1 | 2011 | 597 | 0.020 |
Why?
|
| Disease-Free Survival | 1 | 2011 | 1204 | 0.020 |
Why?
|
| Recurrence | 1 | 2011 | 1139 | 0.020 |
Why?
|
| HLA Antigens | 1 | 2010 | 232 | 0.020 |
Why?
|
| Postoperative Complications | 2 | 2011 | 2207 | 0.020 |
Why?
|
| Hydrocortisone | 1 | 2010 | 298 | 0.020 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p27 | 1 | 2007 | 36 | 0.020 |
Why?
|
| STAT5 Transcription Factor | 1 | 2007 | 42 | 0.020 |
Why?
|
| Cell Growth Processes | 1 | 2007 | 83 | 0.020 |
Why?
|
| Flame Retardants | 1 | 2007 | 1 | 0.020 |
Why?
|
| Octoxynol | 1 | 2007 | 8 | 0.020 |
Why?
|
| Angiotensin I | 1 | 2007 | 6 | 0.020 |
Why?
|
| Infant, Premature | 1 | 2010 | 290 | 0.020 |
Why?
|
| Polybrominated Biphenyls | 1 | 2007 | 5 | 0.020 |
Why?
|
| Time | 1 | 2007 | 77 | 0.020 |
Why?
|
| Myoglobin | 1 | 2007 | 29 | 0.020 |
Why?
|
| Length of Stay | 1 | 2011 | 704 | 0.020 |
Why?
|
| Trypsin | 1 | 2007 | 95 | 0.020 |
Why?
|
| Molecular Weight | 1 | 2007 | 332 | 0.020 |
Why?
|
| Surface-Active Agents | 1 | 2007 | 59 | 0.020 |
Why?
|
| fms-Like Tyrosine Kinase 3 | 1 | 2007 | 127 | 0.020 |
Why?
|
| Gene Rearrangement | 1 | 2007 | 170 | 0.020 |
Why?
|
| Stromal Cells | 1 | 2007 | 143 | 0.020 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2007 | 222 | 0.020 |
Why?
|
| Histone-Lysine N-Methyltransferase | 1 | 2007 | 154 | 0.020 |
Why?
|
| Bone Marrow Cells | 1 | 2007 | 253 | 0.020 |
Why?
|
| Chronic Disease | 1 | 2010 | 973 | 0.020 |
Why?
|
| Double-Blind Method | 1 | 2010 | 1824 | 0.020 |
Why?
|
| Light | 1 | 2007 | 289 | 0.020 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2018 | 3362 | 0.020 |
Why?
|
| Annexin A5 | 1 | 2005 | 20 | 0.020 |
Why?
|
| Cell Cycle | 1 | 2007 | 502 | 0.020 |
Why?
|
| Flow Cytometry | 1 | 2007 | 679 | 0.020 |
Why?
|
| Erythropoiesis | 1 | 2005 | 52 | 0.020 |
Why?
|
| Hypergammaglobulinemia | 1 | 2004 | 8 | 0.020 |
Why?
|
| Splenomegaly | 1 | 2004 | 27 | 0.020 |
Why?
|
| Phosphopyruvate Hydratase | 1 | 2004 | 39 | 0.020 |
Why?
|
| Transplantation, Homologous | 1 | 2007 | 996 | 0.020 |
Why?
|
| Cellular Senescence | 1 | 2005 | 94 | 0.020 |
Why?
|
| Polyethylene Glycols | 1 | 2007 | 364 | 0.020 |
Why?
|
| Up-Regulation | 1 | 2007 | 715 | 0.020 |
Why?
|
| Oceans and Seas | 1 | 2004 | 30 | 0.020 |
Why?
|
| Immunosuppressive Agents | 1 | 2010 | 977 | 0.020 |
Why?
|
| Aspartic Acid | 1 | 2003 | 64 | 0.010 |
Why?
|
| Graft Survival | 1 | 2007 | 885 | 0.010 |
Why?
|
| Bone Marrow | 1 | 2005 | 435 | 0.010 |
Why?
|
| Valine | 1 | 2003 | 69 | 0.010 |
Why?
|
| Laparoscopy | 1 | 2011 | 754 | 0.010 |
Why?
|
| Glycine | 1 | 2003 | 92 | 0.010 |
Why?
|
| Receptors, TNF-Related Apoptosis-Inducing Ligand | 1 | 2002 | 4 | 0.010 |
Why?
|
| CASP8 and FADD-Like Apoptosis Regulating Protein | 1 | 2002 | 13 | 0.010 |
Why?
|
| Caspase 1 | 1 | 2002 | 18 | 0.010 |
Why?
|
| Death Domain Receptor Signaling Adaptor Proteins | 1 | 2002 | 6 | 0.010 |
Why?
|
| Leupeptins | 1 | 2002 | 21 | 0.010 |
Why?
|
| Amino Acid Chloromethyl Ketones | 1 | 2002 | 25 | 0.010 |
Why?
|
| Fatty Acid Desaturases | 1 | 2002 | 17 | 0.010 |
Why?
|
| Fas Ligand Protein | 1 | 2002 | 49 | 0.010 |
Why?
|
| TNF-Related Apoptosis-Inducing Ligand | 1 | 2002 | 25 | 0.010 |
Why?
|
| Drug Screening Assays, Antitumor | 1 | 2002 | 78 | 0.010 |
Why?
|
| Receptors, Tumor Necrosis Factor | 1 | 2002 | 88 | 0.010 |
Why?
|
| Thermodynamics | 1 | 2003 | 309 | 0.010 |
Why?
|
| Cluster Analysis | 1 | 2003 | 369 | 0.010 |
Why?
|
| Surveys and Questionnaires | 1 | 2010 | 2504 | 0.010 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2003 | 315 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 2007 | 1992 | 0.010 |
Why?
|
| Cyclosporine | 1 | 2003 | 234 | 0.010 |
Why?
|
| Thyroidectomy | 1 | 2003 | 170 | 0.010 |
Why?
|
| Autoimmunity | 1 | 2003 | 160 | 0.010 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2002 | 199 | 0.010 |
Why?
|
| Drug Therapy, Combination | 1 | 2004 | 895 | 0.010 |
Why?
|
| Lymph Node Excision | 1 | 2003 | 217 | 0.010 |
Why?
|
| Skin | 1 | 2004 | 554 | 0.010 |
Why?
|
| Antibodies, Monoclonal | 1 | 2007 | 1376 | 0.010 |
Why?
|
| Tumor Cells, Cultured | 1 | 2002 | 1041 | 0.010 |
Why?
|
| Protein Conformation | 1 | 2003 | 881 | 0.010 |
Why?
|
| Recombinant Proteins | 1 | 2002 | 1015 | 0.010 |
Why?
|
| Child, Preschool | 1 | 2007 | 3613 | 0.010 |
Why?
|
| Enzyme Inhibitors | 1 | 2002 | 639 | 0.010 |
Why?
|
| NF-kappa B | 1 | 2002 | 445 | 0.010 |
Why?
|
| Neoplasm Proteins | 1 | 2002 | 532 | 0.010 |
Why?
|
| Carrier Proteins | 1 | 2002 | 673 | 0.010 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2002 | 592 | 0.010 |
Why?
|